Local challenge on oral mucosa with an α-gliadin related synthetic peptide in patients with celiac disease
暂无分享,去创建一个
M. Mäki | S. Syrjänen | I. Räihä | P. Vilja | I. Rantala | A. Toivanen | M. Viander | H. Lähteenoja | I. Räihä
[1] Fernando Gomollón. Celiac sprue. , 2002, The New England journal of medicine.
[2] M. Mäki,et al. Local challenge of oral mucosa with gliadin in patients with coeliac disease , 2000, Clinical and Experimental Immunology.
[3] N. Brousse,et al. Gluten-free diet induces regression of T-Cell activation in the rectal mucosa of patients with celiac disease , 1998, American Journal of Gastroenterology.
[4] F. Koning,et al. Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. , 1998, Journal of immunology.
[5] L. Fugger,et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease , 1998, Nature Medicine.
[6] D. Green,et al. Fas ligand- mediated killing by intestinal intraepithelial lymphocytes. Participation in intestinal graft-versus-host disease. , 1998, The Journal of clinical investigation.
[7] D. Schuppan,et al. Identification of tissue transglutaminase as the autoantigen of celiac disease , 1997, Nature Medicine.
[8] M. Mäki,et al. Intraepithelial lymphocytes bearing the γ/δ receptor in the oral and jejunal mucosa in patients with dermatitis herpetiformis , 1997 .
[9] T. Macdonald,et al. A major role for matrix metalloproteinases in T cell injury in the gut. , 1997, Journal of immunology.
[10] T. Reunala,et al. Intraepithelial lymphocytes bearing the gamma/delta receptor in the oral and jejunal mucosa in patients with dermatitis herpetiformis. , 1997, European journal of oral sciences.
[11] L. Maiuri,et al. In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa. , 1996, Scandinavian journal of gastroenterology.
[12] G. A. Limb,et al. Cytokine mRNA expression in the mucosa of treated coeliac patients after wheat peptide challenge. , 1995, Gut.
[13] H. Wieser. The precipitating factor in coeliac disease. , 1995, Bailliere's clinical gastroenterology.
[14] K. Lundin,et al. Wheat peptide challenge in coeliac disease , 1994, The Lancet.
[15] K. Sletten,et al. In Vitro Toxicity of Purified Gluten Peptides Tested by Organ Culture , 1994, Journal of pediatric gastroenterology and nutrition.
[16] E. Thorsby,et al. Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients , 1993, The Journal of experimental medicine.
[17] T. Halstensen,et al. Activated T lymphocytes in the celiac lesion: Non‐proliferative activation (CD25) of CD4+ α/β cells in the lamina propria but proliferation (Ki‐67) of α/β and γ/δ cells in the epithelium , 1993, European journal of immunology.
[18] E. J. Lew,et al. In vitro (organ culture) studies of the toxicity of specific A-gliadin peptides in celiac disease. , 1988, Gastroenterology.
[19] H. Wieser,et al. Coeliac activity of the gliadin peptides CT-1 and CT-2 , 1986, Zeitschrift fur Lebensmittel-Untersuchung und -Forschung.
[20] T. Okita,et al. Nucleic acid (cDNA) and amino acid sequences of alpha-type gliadins from wheat (Triticum aestivum). , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[21] L. Aksnes,et al. Morphological and morphometric assessment of human duodenal biopsies maintained in organ culture. In vitro influences of gluten in coeliac disease. , 1981, Scandinavian journal of gastroenterology.